George Kollias

Group Photo 2nd International Conference on #Mesenchymal #Cells in #Health & #Disease #chania #Greece

March 15th Registration early fee deadline: 2nd Int'l Conference on #Mesenchymal Cells in Health & Disease aegeanconferences.org/src/App/confer…

Discovery of the First-in-Class Inhibitors of Hypoxia Up-Regulated Protein 1 (HYOU1) Suppressing Pathogenic Fibroblast Activation (George Kollias and co-workers) @KolliasLab onlinelibrary.wiley.com/doi/10.1002/an…

Thrilled that my article made it to the Top 10 most-downloaded! Grateful for the support @NatureRevCancer @BSRC_Fleming #MustRead

Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis: buff.ly/42mYXhy @KolliasLab @BSRC_Fleming #Therapeutics

Sharkey et al. discuss intrinsic neural control of #gut functions involved in digestion and how the enteric nervous system interacts with the #immune system, gut #microbiota, and epithelium to maintain mucosal defense & barrier function ow.ly/ZErO50NF9nA

Two touches are better than one🤓 Our novel concepts on immune stimulating #mesenchymal cells across tissues @NatureRevCancer Plus a reworked model of the “Cancer Immunity Cycle”  based on antigen-presenting #fibroblasts and the “Second Touch Hypothesis”👉rdcu.be/c5PnQ

📢 The results of the 2022 ERC Consolidator Grant competition are out: €657 million for 321 researchers. Who has been offered funding? What topics they will investigate? Where will they do their research? Discover the details ➡️ bit.ly/ERCCoG2022Resu… 🇪🇺#EUfunded #ERCCoG